China Reform Health Management and Services Group (000503.SZ) released the 2024 semi-annual performance forecast. The net income attributable to shareholders of the listed company for the reporting period is expected to be a loss of approximately 75.82 million yuan, a decrease of 11% from the same period last year, when the loss was 84.95 million yuan. After deducting non-recurring gains and losses, the net income is a loss of approximately 81.4 million yuan, a decrease of 10% from the same period last year, when the loss was 90.69 million yuan. The basic earnings per share are expected to be a loss of approximately 0.0774 yuan per share.
The company's business as a whole presents a seasonal characteristic of low in the front and high in the back. During the reporting period, the company firmly focused on the strategic plan of "three medical cooperations, innovation-driven, digital ecology", on the one hand, it focused on enhancing the professional service capabilities of digital medical insurance sector and consolidating its industry position; on the other hand, it accelerated investment in digital medical and digital pharmaceutical sectors, continuously optimizing and improving the product system. During the reporting period, the operating losses of the company have narrowed. It is expected that the net income attributable to shareholders of the listed company will be -75.82 million yuan, a decrease of 11% year-on-year.
